These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 5507848)
21. [Inhibition of lymphocyte transformation in the diffusion-chamber ("in vivo") by L-asparaginase]. Pappas A; Hirschmann WD; Scheurlen PG; Esser W Med Welt; 1970 Jul; 28():1288-91. PubMed ID: 5508100 [No Abstract] [Full Text] [Related]
22. [The proteinuria of myeloma. Comparative study of the abnormal serum and urinary proteins of myeloma by starch gel electrophoresis and immunoelectrophoresis]. DEBRAY-SACHS M; SACHS C Rev Fr Etud Clin Biol; 1962 Nov; 7():927-37. PubMed ID: 14026272 [No Abstract] [Full Text] [Related]
29. A simple technique for the isolation of monoclonal IgG and IgA. Fine JM; Steinbuch M Rev Eur Etud Clin Biol; 1970 Dec; 15(10):1115-21. PubMed ID: 5517893 [No Abstract] [Full Text] [Related]
30. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo. Guo QL; Wu MS; Chen Z Acta Pharmacol Sin; 2002 Oct; 23(10):946-51. PubMed ID: 12370101 [TBL] [Abstract][Full Text] [Related]
31. BCL-X expression in multiple myeloma: possible indicator of chemoresistance. Tu Y; Renner S; Xu F; Fleishman A; Taylor J; Weisz J; Vescio R; Rettig M; Berenson J; Krajewski S; Reed JC; Lichtenstein A Cancer Res; 1998 Jan; 58(2):256-62. PubMed ID: 9443402 [TBL] [Abstract][Full Text] [Related]
32. [CONSIDERATIONS ON THE BLOOD PROTEIN PICTURE IN ELECTROPHORESIS AND ULTRACENTRIFUGATION IN A SERIES OF PATIENTS WITH DIFFUSE PLASMOCYTOMA]. CIRLA E; SALTERI F; FASOLI A Haematol Lat; 1964; 7():77-86. PubMed ID: 14233076 [No Abstract] [Full Text] [Related]
33. Hematopoietic growth factors stimulate paraprotein isotype production by bone marrow mononuclear cells in an aggressive case of multiple myeloma. Säily M; Koistinen P; Laine S; Soppi E; Savolainen ER J Clin Lab Immunol; 1995; 46(1):41-7. PubMed ID: 9363591 [TBL] [Abstract][Full Text] [Related]
34. MYELOMATOSIS WITH XANTHOMATOSIS MULTIFORME. NEUFELD AH; MORTON HS; HALPENNY GW Can Med Assoc J; 1964 Aug; 91(8):374-80. PubMed ID: 14179539 [TBL] [Abstract][Full Text] [Related]
35. Promising preclinical activity of 2-methoxyestradiol in multiple myeloma. Dingli D; Timm M; Russell SJ; Witzig TE; Rajkumar SV Clin Cancer Res; 2002 Dec; 8(12):3948-54. PubMed ID: 12473611 [TBL] [Abstract][Full Text] [Related]
36. [On a case of immunoglobulin D plasmacytoma]. Wiedermann D; Wiedermann B; Rádl J; Skvaril F; Vaerman JP Schweiz Med Wochenschr; 1967 Feb; 97(7):207-10. PubMed ID: 5589271 [No Abstract] [Full Text] [Related]
38. A case of aggressive multiple myeloma with cleaved, multilobated, and monocytoid nuclei, and no serum monoclonal gammopathy. Yeh YA; Pappas AA; Flick JT; Butch AW Ann Clin Lab Sci; 2000 Jul; 30(3):283-8. PubMed ID: 10945569 [TBL] [Abstract][Full Text] [Related]
39. [Binding of the antileukemia drug Escherichia coli L-asparaginase to the plasma membrane of normal human mononuclear cells]. Mercado-Vianco L; Arenas-Díaz G Sangre (Barc); 1999 Jun; 44(3):204-9. PubMed ID: 10481582 [TBL] [Abstract][Full Text] [Related]
40. Proposed guidelines for protocol studies. II. Plasma cell myeloma. Prepared by a Committee of the Chronic Leukemia--Myeloma Task Force, National Cancer Institute. Cancer Chemother Rep 3; 1968 Dec; 1(1):17-39. PubMed ID: 4195760 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]